Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783868 · ClinicalTrials.gov registry record
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
A clinical trial, sponsored by Kansas City Heart Rhythm Research Foundation.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06783868: Clinical Trial study, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT06783868 is a clinical trial that has not yet begun recruiting, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06783868 has not yet begun recruiting, sponsored by Kansas City Heart Rhythm Research Foundation.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.
Primary Outcome
Modified Rankin Scale is widely used to assess neurologic dysfunction in a broad range of neurologic and neurosurgical conditions. It is a 6-level ordinal outcome scale (0-5) used to assess the functional status of patients, encoding the range from no symptoms or functional impairment (mRS = 0) to severe disability requiring constant nursing care (mRS = 5)
Interventions
- DEVICE Catheter Ablation
- DRUG Market-approved AVNB, OAC and AAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10 |
| Est. Completion | 2027-06 |
What is known before NCT06783868 opens enrollment
NCT06783868 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Catheter Ablation is the first listed.
NCT06783868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06783868 about?
NCT06783868 is a clinical study titled "Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control". A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.
What is the current status of trial NCT06783868?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2025-10. Estimated completion is 2027-06.
What interventions are being tested in trial NCT06783868?
The interventions under investigation include: Catheter Ablation (DEVICE), Market-approved AVNB, OAC and AAD (DRUG).
Who is sponsoring clinical trial NCT06783868?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia